Literature DB >> 10894965

Three cases of pityriasis rubra pilaris successfully treated with cyclosporin A.

K Usuki1, M Sekiyama, T Shimada, S Shimada, T Kanzaki.   

Abstract

BACKGROUND: Pityriasis rubra pilaris (PRP) is reported to respond poorly to cyclosporin A (CsA).
OBJECTIVE: We attempted to determine the efficacy of CsA in the treatment of classic adult-type PRP.
METHODS: Three patients with classic adult-type PRP were treated with 5 mg/kg/day CsA.
RESULTS: A sustained clinical response was achieved within 2-4 weeks of therapy. Relapses were noted when the CsA dose was decreased to 1.2 mg/kg/day.
CONCLUSION: CsA should be considered in the treatment of classical adult-type PRP. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10894965     DOI: 10.1159/000018397

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  1 in total

Review 1.  Management of refractory pityriasis rubra pilaris: challenges and solutions.

Authors:  Gaia Moretta; Erika V De Luca; Alessandro Di Stefani
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-11-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.